Cargando…

Translational Strategies to Target Metastatic Bone Disease

Metastatic bone disease is a common and devastating complication to cancer, confounding treatments and recovery efforts and presenting a significant barrier to de-escalating the adverse outcomes associated with disease progression. Despite significant advances in the field, bone metastases remain pr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pagnotti, Gabriel M., Trivedi, Trupti, Mohammad, Khalid S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9030480/ https://www.ncbi.nlm.nih.gov/pubmed/35455987 http://dx.doi.org/10.3390/cells11081309

Ejemplares similares

The Role of TGF-β in Bone Metastases
por: Trivedi, Trupti, et al.
Publicado: (2021)

Editorial: Bone and muscle interactions in bone pathologies
por: Trivedi, Trupti, et al.
Publicado: (2023)

Increased S1P expression in osteoclasts enhances bone formation in an animal model of Paget's disease
por: Nagata, Yuki, et al.
Publicado: (2020)

Metastatic disease to the liver: Locoregional therapy strategies and outcomes
por: Zane, Kylie E, et al.
Publicado: (2021)

A Review of Translational Research for Targeted Therapy for Metastatic Colorectal Cancer
por: Ruff, Samantha M., et al.
Publicado: (2023)

Role of FNAC in Extramammary Tumors Metastatic to the Breast
por: Tandon, Arshi, et al.
Publicado: (2020)

Exercise Regulation of Marrow Adipose Tissue
por: Pagnotti, Gabriel M., et al.
Publicado: (2016)

Recent developments and translational aspects in targeted therapy for metastatic breast cancer
por: Marhold, Maximilian, et al.
Publicado: (2016)

High Fat Diet Rapidly Suppresses B Lymphopoiesis by Disrupting the Supportive Capacity of the Bone Marrow Niche
por: Adler, Benjamin J., et al.
Publicado: (2014)

Medulloblastoma under Siege: Genetic and Molecular Dissection Concerning Recent Advances in Therapeutic Strategies
por: Rawal, Zeal D, et al.
Publicado: (2020)

Advancing Treatment of Bone Metastases through Novel Translational Approaches Targeting the Bone Microenvironment
por: Sethakorn, Nan, et al.
Publicado: (2022)

Targeted Palliative Radionuclide Therapy for Metastatic Bone Pain
por: Manafi-Farid, Reyhaneh, et al.
Publicado: (2020)

Hypoxic Microenvironment and Metastatic Bone Disease
por: Hiraga, Toru
Publicado: (2018)

The checkpoint inhibitor PD-1H/VISTA controls osteoclast-mediated multiple myeloma bone disease
por: Fu, Jing, et al.
Publicado: (2023)

Targeting Bone Metastases in Metastatic Castration-Resistant Prostate Cancer
por: El-Amm, Joelle, et al.
Publicado: (2016)

Targeting strategies for bone diseases: signaling pathways and clinical studies
por: Xu, Hao, et al.
Publicado: (2023)

Zoledronic acid in the management of metastatic bone disease
por: Polascik, Thomas J, et al.
Publicado: (2008)

A short account of metastatic bone disease
por: Feller, Liviu, et al.
Publicado: (2011)

Current Overview of Treatment for Metastatic Bone Disease
por: Tsukamoto, Shinji, et al.
Publicado: (2021)

Picornavirus translation strategies
por: Francisco‐Velilla, Rosario, et al.
Publicado: (2022)

Bone Targeting Agents in Patients with Metastatic Prostate Cancer: State of the Art
por: Mollica, Veronica, et al.
Publicado: (2021)

Immunocapture strategies in translational proteomics
por: Fredolini, Claudia, et al.
Publicado: (2016)

State-of-the-art imaging for diagnosis of metastatic bone disease
por: Isaac, Amanda, et al.
Publicado: (2020)

Bone/cartilage targeted hydrogel: Strategies and applications
por: Zhang, Hao, et al.
Publicado: (2022)

Targeting Intercellular Communication in the Bone Microenvironment to Prevent Disseminated Tumor Cell Escape from Dormancy and Bone Metastatic Tumor Growth
por: Kreps, Lauren M., et al.
Publicado: (2021)

Translational Implications for Radiosensitizing Strategies in Rhabdomyosarcoma
por: Pomella, Silvia, et al.
Publicado: (2022)

Microenvironment-targeted strategy steers advanced bone regeneration
por: Hao, Shuyue, et al.
Publicado: (2023)

Recent and Future Strategies to Overcome Resistance to Targeted Therapies and Immunotherapies in Metastatic Colorectal Cancer
por: Dazio, Giulia, et al.
Publicado: (2022)

Bone-Targeted Therapies in Metastatic Castration-Resistant Prostate Cancer: Evolving Paradigms
por: El-Amm, Joelle, et al.
Publicado: (2013)

Targeting Post-Translational Modifications of the p73 Protein: A Promising Therapeutic Strategy for Tumors
por: Omran, Ziad, et al.
Publicado: (2021)

Targeting the Metastatic Bone Microenvironment by MicroRNAs
por: Haider, Marie-Therese, et al.
Publicado: (2018)

Post‐translationally modified neoantigens: Promising targets for diagnostic strategy of autoimmune diseases
por: Zhai, Yue, et al.
Publicado: (2023)

MicroRNAs: Emerging Regulators of Metastatic Bone Disease in Breast Cancer
por: Haider, Marie-Therese, et al.
Publicado: (2022)

Metastatic bone disease: Pathogenesis and therapeutic options: Up-date on bone metastasis management
por: D'Oronzo, Stella, et al.
Publicado: (2018)

Bone Marrow Environment in Metastatic Neuroblastoma
por: Brignole, Chiara, et al.
Publicado: (2021)

In Vivo and In Vitro Models of Hepatocellular Carcinoma: Current Strategies for Translational Modeling
por: Romualdo, Guilherme Ribeiro, et al.
Publicado: (2021)

Stress in Metastatic Breast Cancer: To the Bone and Beyond
por: Lourenço, Catarina, et al.
Publicado: (2022)

Nanomaterials-Based Novel Immune Strategies in Clinical Translation for Cancer Therapy
por: Wahab, Shadma, et al.
Publicado: (2023)

Targeting the Complement–Sphingolipid System in COVID-19 and Gaucher Diseases: Evidence for a New Treatment Strategy
por: Trivedi, Vyoma Snehal, et al.
Publicado: (2022)

Minimally Invasive Interventional Procedures for Metastatic Bone Disease: A Comprehensive Review
por: Papalexis, Nicolas, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_jpjnpjtq3kbim3rat0iee5rk5i